Most Recent
Judge was wrong to halt cross-examination in Octaviar class action, court hears
A judge that dismissed an investor class action against the Public Trustee of Queensland over the failure of investment firm Octaviar Group improperly intervened in the cross-examination of one of the class' witnesses, one of the judges that will hear an appeal of the dismissal was told.
Full Court puts injector pen patent appeal on fast track
The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
ASIC asks High Court to clarify meaning of ‘officer’
ASIC is seeking approval from the High Court to appeal a judgment that let a former director of Gold Coast finance company MFS Group partially off the hook for $147.5 million in misappropriated funds, saying the High Court needs to clarify the scope of the word "officer" under the Corporations Act.
Class loses appeal over fatal Christmas Island boat crash
The families of asylum seekers who died in the 2010 Christmas Island boat crash have lost an appeal of a ruling that dismissed their class action against Australia.
Sandoz appeals loss in 15-year battle over Lexapro patent
Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck's blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.
Octaviar investors, class action funder dodge indemnity costs
The investor behind a failed class action against the Public Trustee of Queensland over the collapse of Octaviar Group has escaped a bid by the Trustee for maximum costs, with a judge ruling the case was not a "nakedly speculative venture" by the funder.
Sanofi takes another stab at injunction in injector pen patent case
French pharmaceutical giant Sanofi has appealed a judge's ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
Full Court tosses ACCC appeal in Medibank disclosure case
The Australian Competition and Consumer Commission has lost an appeal of a ruling that dismissed its case over allegedly inadequate disclosures by private health insurer Medibank relating to member benefits.
Appealing GetSwift class action ruling comes at a cost, Full Court says
The law firms that challenged a ruling staying their cases against GetSwift gave the Full Federal Court a chance to guide judges managing competing class actions, but they can't avoid paying their opponents' legal costs because the court happened to seize the opportunity.
Lead applicant socked with costs of Banksia class member’s appeal
The lead applicant in a class action over the failure of Banksia Securities is on the hook for paying the legal costs of a class member who successfully challenged the funder's cut of a $64 million settlement in the case.